Top Markets
Coin of the day
Anteris Technologies Global Corp. Anteris Technologies Global Corp.

Anteris Technologies Global Corp.

AVR
株式のランク #10272
Anteris Technologies Global Corp. is a structural heart innovator dedicated to... Anteris Technologies Global Corp. is a structural heart innovator dedicated to discovering, developing, and bringing to market medical devices that enhance the well-being of patients grappling with aortic stenosis. The company's premier offering is the DurAVR transcatheter heart valve system, a pioneering transcatheter aortic valve engineered to treat aortic stenosis by precisely emulating the performance of a healthy human aortic valve. Beyond this, Anteris develops ADAPT anti-calcification tissue, a unique preparation that transforms xenograft tissue into robust bioscaffolds. These bioscaffolds are designed to simulate human tissue for various surgical repairs, notably in aortic valve replacement. Additionally, the ComASUR delivery system, a physician-designed balloon-expandable apparatus, features a reinforced, steerable catheter. This allows for highly accurate navigation through cardiac anatomy in a controlled manner, thereby mitigating potential damage to the aorta. Founded in 1999, Anteris Technologies Global Corp. operates out of Toowong, Australia.
株価
$8.88
最終同期: 2026-08-28
時価総額
$863.29M
変化(1日)
-1.02%
変化(1年)
120.86%
US
取引 Anteris Technologies Global Corp. (AVR)

カテゴリー

Anteris Technologies Global Corp.(AVR)の株価履歴
終値の最高値: $9.07 (2026-08-01)

終値の最安値: $5.59 (2024-12-01)
Anteris Technologies Global Corp. の株価履歴(2024 ~ 2026)
年間株価パフォーマンス
パフォーマンス
2026 (TTM) 28.26%
2025 -11.64%
2024 0.00%
類似企業または競合の株価
企業 株価 変化率 1年%
$112.64 -15.09%
US
$331.44 -15.32%
US
$91.30 -1.63%
IE
$46.83 -55.61%
US
$46.88 -15.20%
DE